Publications by authors named "Aline Renneville"

82Publications

Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia.

Clin Cancer Res 2017 Oct 28;23(20):6325-6335. Epub 2017 Jul 28.

Service d'Hématologie et Thérapie cellulaire, Centre d'Investigation Clinique, Hôpital de la Milétrie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0007DOI Listing
October 2017

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

J Clin Oncol 2017 Jan 14;35(2):185-193. Epub 2016 Nov 14.

Marie Balsat, Xavier Thomas, and Sandrine Hayette, Centre Hospitalier Lyon Sud, Pierre Benite; Aline Renneville, Alice Marceau, Olivier Nibourel, Céline Rodriguez, and Claude Preudhomme, CHRU of Lille; Aline Renneville, Alice Marceau, Olivier Nibourel, and Claude Preudhomme, Cancer Research Institute of Lille and Université Lille; and Céline Berthon, Claude Huriez Hospital, Lille; Stéphane de Botton, Institut Gustave Roussy, Villejuif; Denis Caillot, Dijon University Hospital, Dijon; Emilie Lemasle, Henri-Becquerel Center, Rouen; Jean-Pierre Marolleau, Amiens University Hospital, Amiens; Emmanuel Raffoux, Hervé Dombret, Jean-Michel Cayuela, Marie Magdeleine Coudé, Karine Celli-Lebras, and Nicolas Boissel, Hôpital Saint-Louis, AP-HP; Emmanuel Raffoux, Herve Dombret, and Nicolas Boissel, University 7 Paris Diderot; and Thorsten Braun, Hôpital Avicennes, AP-HP, Paris; Arnaud Pigneux, Haut-Leveque Hospital, Pessac; Norbert Vey, Paoli-Calmette Institute, Marseille; and Christine Terre, Hôpital de Versailles, Le Chesnay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1875DOI Listing
January 2017

Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.

Expert Rev Hematol 2016 Dec 21;9(12):1189-1202. Epub 2016 Nov 21.

a Laboratory of Hematology , CHU Lille , Lille , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1257936DOI Listing
December 2016

Assessment of Minimal Residual Disease in Standard-Risk AML.

N Engl J Med 2016 08;375(6):e9

Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1603847DOI Listing
August 2016

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.

Blood 2016 Feb 1;127(6):749-60. Epub 2015 Dec 1.

Assistance Publique-Hôpitaux de Paris, Service d'Hématologie Biologique, Hôpitaux Universitaires Paris Centre, Paris, France; Institut Cochin, INSERM U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-640128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937206PMC
February 2016

Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group.

Leuk Res 2015 Dec 9;39(12):1443-7. Epub 2015 Oct 9.

Hematology Laboratory, Biology and Pathology Center, CHRU of Lille, France; University of Lille Nord de France, Lille, France; UMR-S 1172, Team 3, Cancer Research Institute of Lille, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.09.021DOI Listing
December 2015

B7-H3 protein expression in acute myeloid leukemia.

Cancer Med 2015 Dec 17;4(12):1879-83. Epub 2015 Sep 17.

INSERM, UMR 1172, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123710PMC
December 2015

EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

Blood 2015 Oct 28;126(16):1930-9. Epub 2015 Aug 28.

Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-06-649087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608240PMC
October 2015

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes.

Leuk Res 2015 Jul 4. Epub 2015 Jul 4.

Molecular Oncology Unit, Department of Biochemistry, Hospital Saint Louis, AP-HP, Paris, France; Univ Paris Diderot, Sorbonne Paris Cité, CNRS UMR7212/INSERM U944, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.07.001DOI Listing
July 2015

Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21).

Leuk Lymphoma 2016 15;57(1):199-200. Epub 2015 May 15.

a Laboratory of Hematology and Tumor Bank, INSERM U837 Team 3, Cancer Research Institute of Lille, Centre Hospitalier Régional Universitaire of Lille, University Lille Nord de France , Lille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1037754DOI Listing
October 2016

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.

Oncotarget 2014 Jun;5(12):4384-91

INSERM U1065, Mediterranean Center for Molecular Medicine (C3M), Nice, France; University of Nice, Nice, France; Department of Clinical hematology and Transplantation, CHU of Nice, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147331PMC
http://dx.doi.org/10.18632/oncotarget.2024DOI Listing
June 2014

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.

Leuk Res 2014 Jul 23;38(7):751-5. Epub 2014 Mar 23.

Department of Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis, Université Paris 7, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.03.012DOI Listing
July 2014

SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL.

Blood 2014 Mar 21;123(12):1860-3. Epub 2014 Jan 21.

Université de Médecine Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, Institut National de la Santé et de la Recherche Médicale U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-08-521518DOI Listing
March 2014

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

J Clin Oncol 2014 Feb 16;32(4):297-305. Epub 2013 Dec 16.

Maxime Janin, Robert Barouki, Daniel Rabier, and Chris Ottolenghi, Biochimie Métabolique, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Necker-Enfants Malades; Maxime Janin, Robert Barouki, and Chris Ottolenghi, Institut National de la Santé et de la Recherche Médicale (INSERM) U747, Université Paris Descartes; Hervé Dombret, Hôpital Saint-Louis, Paris; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Olivier Adrien Bernard, Virginie Penard-Lacronique, and Stéphane de Botton, INSERM U985, Institut Gustave Roussy; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Eric Solary, Olivier Adrien Bernard, and Virginie Penard-Lacronique, Institut Fédératif de Recherche 54, Institut Gustave Roussy; Véronique Saada, Sébastien Forget, Nathalie Auger, Frank Griscelli, Elisabeth Chachaty, Edwige Leclercq, Marie-Hélène Courtier, and Annelise Bennaceur-Griscelli, Institut Gustave Roussy; Jean-Baptiste Micol and Stéphane de Botton, Hématologie Clinique, Institut Gustave Roussy; Serge Koscielny, Service de Biostatistique et d'Epidémiologie, Institut Gustave Roussy, Villejuif; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Olivier Adrien Bernard, Virginie Penard-Lacronique, Chris Ottolenghi, and Stéphane de Botton, Université Paris Sud-11, Orsay; Aline Renneville and Claude Preudhomme, Hématologie Biologique, Centre Hospitalier Régional Universitaire (CHRU) Lille; Céline Berthon, Hématologie Clinique, CHRU Lille, Lille; Cécile Pautas, Hématologie Clinique, Centre Hospitalier Henri Mondor, Créteil; and Denis Caillot, Hématologie Clinique, Centre Hospitalier Universitaire Dijon, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.2047DOI Listing
February 2014

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Medicine (Baltimore) 2013 Sep;92(5):e1-e9

From the French Eosinophil Network-EA-2686 and Department of Immunology (FL, SM, DL, SD, LP, JEK); Laboratory of Hematology, INSERM U837-Institut de Recherche contre le Cancer (AR, CP); Department of Internal Medicine (PYH); and INSERM U995 (MC), CHRU de Lille, Université Lille-Nord de France, Lille; CNRS UMR 8147 and Department of Hematology (EM), Hôpital Necker-Enfants Malades Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-5 Descartes, Paris; Department of Internal Medicine (FA, OB, JEK), Hôpital Foch, Université Versailles Saint-Quentin en Yvelines, Suresnes; Laboratory of Hematology (JMC), Hôpital Saint-Louis (AP-HP), Université Paris-7 Diderot, Paris; Department of Hematology (PR), Hôpital André Mignot, Université Versailles Saint-Quentin en Yvelines, Le Chesnay; Department of Hematology (AST), CHU Angers, Angers; Department of Internal Medicine (OF), Hôpital Jean Verdier (AP-HP), Bondy; Department of Internal Medicine (MM), Hôpital Henri Mondor (AP-HP), Créteil; Department of Internal Medicine and Oncology (JPdJ), Hôpital d'Instruction des Armées Sainte-Anne, Toulon; Department of Hematology (PCM), Centre Hospitalier d'Annecy, Pringy; Department of Internal Medicine (DS), Hôpital Lariboisière (AP-HP), Paris; Department of Pneumology (VC), Hôpital Louis Pradel-Hospices Civils de Lyon, Lyon; Department of Internal Medicine A (MH), CHU Hotel-Dieu, Nantes; Department of Internal Medicine (OL), Hôpital Bichat-Claude Bernard (AP-HP), Paris; and Department of Pediatric Hematology (AB), Hôpital Robert Debré (AP-HP), Paris; France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3182a71ebaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553979PMC
September 2013

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.

Blood 2012 Sep 7;120(13):2719-22. Epub 2012 Jun 7.

Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche (UMR) 1009, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-04-422352DOI Listing
September 2012

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

Leuk Res 2012 Mar 29;36(3):316-23. Epub 2011 Nov 29.

UR Biologie Moléculaire des leucémies et lymphomes, Faculté de Médecine de Sousse, Université de Sousse, Tunisia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.11.002DOI Listing
March 2012

Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.

Br J Haematol 2010 Dec 19;151(5):460-8. Epub 2010 Oct 19.

Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Département de Génétique; Université Paris 7-Denis Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2010.08393.xDOI Listing
December 2010